Susanna Miettinen

Prof. Dr. Susanna Miettinen

Adult Stem Cell Group, Tampere University, Tampere, Finland
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2009 in International Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
KMK. Mesimäki
K. Mesimäki
BLB. Lindroos
B. Lindroos
JTJ. Törnwall
J. Törnwall
JMJ. Mauno
J. Mauno
CLC. Lindqvist
C. Lindqvist
RSR. Suuronen
R. Suuronen

18 September 2010 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
BLBettina Lindroos
Bettina Lindroos
RSRiitta Seppänen-Kaijansinkko
Riitta Seppänen-Kaijansinkko
Susanna MiettinenSusanna Miettinen
Susanna Miettinen

1 January 2009 in Cytotherapy
Verified
Journal Article
Closed access
BLBettina Lindroos
Bettina Lindroos
SBShayne Boucher
Shayne Boucher
LCLucas Chase
Lucas Chase
HKHannu Kuokkanen
Hannu Kuokkanen
HHHeini Huhtala
Heini Huhtala
Susanna MiettinenSusanna Miettinen
Susanna Miettinen

20 February 2014 in Stem Cells Translational Medicine
Verified
Journal Article
Open access
PDF file
GSGyörgy K Sandor
György K Sandor
JNJura Numminen
Jura Numminen
JWJan Wolff
Jan Wolff
TTTuomo Thesleff
Tuomo Thesleff
AMAimo Miettinen
Aimo Miettinen
JÖJuha Öhman
Juha Öhman
Although isolated reports of hard-tissue reconstruction in the cranio-maxillofacial skeleton exist, multipatient case series are lacking. This study aimed to review the experience with 13 consecutive cases of cranio-maxillofacial hard-tissue defects at four anatomically different sites, namely frontal sinus (3 cases), cranial bone (5 cases), mandible (3 cases), and nasal septum (2 cases). Autologous adipose tissue was harvested from the anterior abdominal wall, and adipose-derived stem cells were cultured, expanded, and then seeded onto resorbable scaffold materials for subsequent reimplantation into hard-tissue defects. The defects were reconstructed with either bioactive glass or β-tricalcium phosphate scaffolds seeded with adipose-derived stem cells (ASCs), and in some cases with the addition of recombinant human bone morphogenetic protein-2. Production and use of ASCs were done according to good manufacturing practice guidelines. Follow-up time ranged from 12 to 52 months. Successful integration of the construct to the surrounding skeleton was noted in 10 of the 13 cases. Two cranial defect cases in which nonrigid resorbable containment meshes were used sustained bone resorption to the point that they required the procedure to be redone. One septal perforation case failed outright at 1 year because of the postsurgical resumption of the patient's uncontrolled nasal picking habit.

4 November 2014 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
Clarisse RibeiroClarisse Ribeiro
Clarisse Ribeiro
JPJenita Pärssinen
Jenita Pärssinen
Vitor SencadasVitor Sencadas
Vitor Sencadas
VCVítor Manuel Gomes Correia
Vítor Manuel Gomes Correia
Susanna MiettinenSusanna Miettinen
Susanna Miettinen
Senentxu Lanceros-MendezSenentxu Lanceros-Mendez
Senentxu Lanceros-Mendez

1 April 2008 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
BLBettina Lindroos
Bettina Lindroos
KMKatja Mäenpää
Katja Mäenpää
TYTimo Ylikomi
Timo Ylikomi
HOHannu Oja
Hannu Oja
RSRiitta Seppänen-Kaijansinkko
Riitta Seppänen-Kaijansinkko
Susanna MiettinenSusanna Miettinen
Susanna Miettinen